The effects of 5-hydroxytryptamine (5-HT), 5-HT2 receptor antagonists ( 
Introduction
Total blood flow, vasomotion (spontaneous rhythmical varia¬ tions in arteriolar blood flow) and vascular permeability in the testis are apparently influenced by factors secreted by Leydig cells and seminiferous tubules (for references see Bergh and Damber, 1993) , but the nature of these factors and their physiological and pathophysiological importance is largely unknown. Other cell types in the testis could also be involved in the local regulation of the testicular vasculature. Mast cells, which are a major source of vasoactive substances, and inflammation mediators like 5-hydroxytryptamine (5-HT) and histamine, are present around the subcapsular part of the main testicular artery (Sowerbutts et al, 1986) , and mast cells are probably involved in the control of blood flow in other steroid hormone producing organs like the ovary (Krishna et al, 1989) and the adrenal cortex (Hinson et al, 1989) . Treatment with hCG causes mast cell degranulation (Morales and Heyn, 1992) (Bergh and Damber, 1993 (Campos et al, 1990) , and Leydig cells in response to hCG stimulation (Tinajero et al, 1993a, b) . Ketan¬ serin (a 5-HT antagonist) inhibits the hCG-induced increase in testicular interstitial fluid volume (Sowerbutts et al, 1986) . In addition, 5-HT is known to induce vasoconstriction in the main testicular artery (Free, 1977; Davis, 1992) and high doses cause testicular ischaemia and atrophy (Free, 1977) . In addition, it has been demonstrated that 5-HT is an important autocrine or paracrine regulator of Leydig cell function (Dufau et al, 1993; Tinajero et al, 1993a, b) and that Leydig cells play a key role in regulating testicular blood flow (Bergh and Damber, 1993) .
Materials and Methods

Materials
Radioactive microspheres (16.5 (Fig. 3) . The linear correlation coeffi¬ cients between dose of 5-HT and change in blood flow and duration of the response were 0.70 (P < 0.002) and 0.76 (P< 0.001), respectively. (Nagai et al, 1992 ). Morales and Heyn (1992) suggested that hCG treatment causes degranulation of testicular mast cells 6 h and 24 h after (Hinson et al, 1989) and ovary (Krishna et al, 1989) , respectively. Testicular blood flow is decreased 6 h after LH/hCG treatment (van Vliet et al, 1988; Widmark et al, 1989) , but whether this is related to release of 5-HT remains unknown. Treatment with LH/hCG also induces an inflammation-like increase in vascular permeability in the testis (Bergh and Damber, 1993) , but this response is probably not related to release of mast cell products like 5-HT and histamine, since local injection of these substances into the testis does not influence vascular permeability (Bergh and Söder, 1990; Setchell et al, 1988) .
5-Hydroxytryptamine antagonist (ritanserin, ketanserin
The concentration of 5-HT in rat plasma is reported to be 3.9 ng ml-1 and in testicular interstitial fluid to 23 ng ml- (Campos et al, 1990) . The high content in interstitial fluid could be an overestimation, as 5-HT could have been released from cells during the collection of interstitial fluid (Maddocks and Setchell, 1988 (Campos et al, 1990) and Leydig cells (Tinajero et al, 1993b) . The relative contributions from these sources are unknown, and there is no information available on whether intratesticular 5-HT concentration in vivo is influenced by physiological regulators of testicular function.
The only information available is that denervation reduced intratesticular 5-HT by 34% (Campos et al, 1990) . It has been shown, however, that 5-HT could be an important autocrine or paracrine regulator of Leydig cell function (Dufau et al, 1993; Tinajero et al, 1993a, b (Dufau el al, 1993; Tinajero et al, 1993b ) and previous studies have demonstrated testicular atrophy after administration in high doses (see Free, 1977 (Yang et al, 1990 (Yang et al, , 1992 . Stimulation of rat testis with high doses of hCG may induce focal degenera¬ tion of seminiferous tubules (van Vliet et al, 1988) , but it remains to be shown whether this could be caused by an hCG-induced secretion of locally produced vasoconstrictors.
